Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
South African radio presenter among five charged over Russia recruitment plot - 2Could the Star of Bethlehem have actually been a comet?
- 3What's going around right now? COVID, flu, stomach bug on the rise
- 4UN estimates over 2,000 Sudanese pregnant women have fled el-Fasher to escape conflict
- 5Surging measles cases are 'fire alarm' warning that other diseases could be next
- As cases of a rare, deadly infection rise, doctors worry fewer teens will get vaccinated
- What to watch for in weight loss drugs in 2026
- What is the 'Survivor 50' Challenge? Hidden immunity idols will be up for grabs in every U.S. state.
- Texas cities have some of the highest preterm birth rates in the US, highlighting maternal health crisis nationwide
- The most effective method to Pick a Campervan That Offers Something else for Less
- A top Marine shares his secrets to keeping fit at 50
- Russia patents space station designed to generate artificial gravity
- Interstellar comet 3I/ATLAS reveals weird wobbling jets in rare sun-facing tail
- Vote in favor of Your #1 Climbing boots Now
